ClariVest Asset Management LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 129 filers reported holding ANI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,980
+47.4%
51,338
+36.7%
0.16%
+58.8%
Q2 2023$2,022
-99.6%
37,546
+101.4%
0.10%
+385.7%
Q1 2022$524,000
-47.3%
18,643
-13.7%
0.02%
-32.3%
Q4 2021$995,000
+99400.0%
21,596
+50123.3%
0.03%
Q3 2021$1,000
-100.0%
43
-99.9%
0.00%
-100.0%
Q1 2015$2,536,000
+16.8%
40,550
+5.3%
0.08%0.0%
Q4 2014$2,172,000
+70.6%
38,524
-14.4%
0.08%
+63.8%
Q3 2014$1,273,000
-18.0%
45,001
-0.1%
0.05%
-20.3%
Q2 2014$1,552,000
-12.6%
45,036
-20.5%
0.06%
-18.1%
Q1 2014$1,775,00056,6140.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders